Stony Brook Medicine/Southampton hospital, Southampton, NY, United States.
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006, India.
Aesthetic Plast Surg. 2022 Apr;46(Suppl 1):94-95. doi: 10.1007/s00266-021-02452-8. Epub 2021 Jul 6.
This is a letter to the editor about a meta-analysis titled "The efficacy of cell-assisted lipotransfer versus conventional lipotransfer in breast augmentation: a systematic review and meta-analysis" by Li and Chen published in the year 2021. The most frequently performed aesthetic procedure is breast augmentation surgery. In breast augmentation, cell-assisted lipotransfer (CAL) has received high recognition due to its positive outcomes. There are controversies in the medical literature on the use of CAL for breast augmentation. This meta-analysis by Li and Chen has concluded that CAL using ASC was superior to other methods as it improved fat survival rate in breast augmentation. We have written this letter to the editor of the Aesthetic Plastic Surgery journal about this meta-analysis because of its impactful information provided by this study to the medical literature for breast augmentation surgery using cell-assisted lipotransfer. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
这是一封针对李和陈在 2021 年发表的题为“细胞辅助脂肪转移与传统脂肪转移在隆乳中的疗效:系统评价和荟萃分析”的荟萃分析的社论信。最常进行的美容手术是隆胸手术。在隆胸术中,细胞辅助脂肪转移 (CAL) 因其良好的效果而受到高度认可。在使用 CAL 进行隆胸的医学文献中存在争议。李和陈的这项荟萃分析得出的结论是,使用 ASC 的 CAL 优于其他方法,因为它提高了隆胸中脂肪的存活率。我们之所以向《美容整形外科学杂志》的编辑写这封社论信,是因为这项研究为使用细胞辅助脂肪转移的隆胸手术提供了有影响力的医学文献信息。证据水平 V 本杂志要求作者为每篇文章分配一个证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南 www.springer.com/00266。